Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Immunological Methods
|
November 5, 1991
Investigation and prevention of artifactual staining in flow cytometric analyses of whole blood samples from patients treated with H65-RTA, an anti-CD5 monoclonal antibody conjugated to ricin A chain
D M Fishwild, E A Saria
Journal of Surgical Oncology
|
March 1, 1996
Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance
L J Layfield, E A Saria, D H Conlon, et al.
Journal of Cutaneous Pathology
|
July 5, 2001
Intrauterine epidermal necrosis
J E Allee, E A Saria, D Rosenblum, et al.
Therapeutic Immunology
|
April 1, 1994
Evaluation of anti-CD5 ricin A chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation
D Przepiorka, C F LeMaistre, Y O Huh, et al.
Journal of Surgical Oncology
|
January 13, 1998
Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis
L J Layfield, E A Saria, A Berchuck, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
April 1, 1993
Phase I/II study of murine monoclonal antibody-ricin A chain (XOMAZYME-Mel) immunoconjugate plus cyclosporine A in patients with metastatic melanoma
K Selvaggi, E A Saria, R Schwartz, et al.
Journal of Diabetes and Its Complications
|
October 1, 1993
Effects of an anti-CD5 immunoconjugate (CD5-plus) in recent onset type I diabetes mellitus: a preliminary investigation. The CD5 Diabetes Project Team
J S Skyler, T J Lorenz, S Schwartz, et al.
Oncogene
|
September 27, 2006
PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumors
A M Deshpande, J D Akunowicz, X T Reveles, et al.
Cancer Research
|
December 26, 2001
Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma
S Zha, W R Gage, J Sauvageot, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Immunological Methods
|
November 5, 1991
Investigation and prevention of artifactual staining in flow cytometric analyses of whole blood samples from patients treated with H65-RTA, an anti-CD5 monoclonal antibody conjugated to ricin A chain
D M Fishwild, E A Saria
Journal of Surgical Oncology
|
March 1, 1996
Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance
L J Layfield, E A Saria, D H Conlon, et al.
Journal of Cutaneous Pathology
|
July 5, 2001
Intrauterine epidermal necrosis
J E Allee, E A Saria, D Rosenblum, et al.
Therapeutic Immunology
|
April 1, 1994
Evaluation of anti-CD5 ricin A chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation
D Przepiorka, C F LeMaistre, Y O Huh, et al.
Journal of Surgical Oncology
|
January 13, 1998
Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis
L J Layfield, E A Saria, A Berchuck, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
April 1, 1993
Phase I/II study of murine monoclonal antibody-ricin A chain (XOMAZYME-Mel) immunoconjugate plus cyclosporine A in patients with metastatic melanoma
K Selvaggi, E A Saria, R Schwartz, et al.
Journal of Diabetes and Its Complications
|
October 1, 1993
Effects of an anti-CD5 immunoconjugate (CD5-plus) in recent onset type I diabetes mellitus: a preliminary investigation. The CD5 Diabetes Project Team
J S Skyler, T J Lorenz, S Schwartz, et al.
Oncogene
|
September 27, 2006
PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumors
A M Deshpande, J D Akunowicz, X T Reveles, et al.
Cancer Research
|
December 26, 2001
Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma
S Zha, W R Gage, J Sauvageot, et al.
Page
of 1